🇩🇪 Kyprolis in Germany

Kyprolis (carfilzomib) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Kyprolis
  • Status: approved

Kyprolis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Kyprolis approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Kyprolis in Germany?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.